Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
93,341,618
-
Share change
-
+10,002,372
-
Total reported value
-
$543,213,500
-
Put/Call ratio
-
95%
-
Price per share
-
$5.82
-
Number of holders
-
126
-
Value change
-
+$57,718,638
-
Number of buys
-
73
-
Number of sells
-
50
Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q3 2022
As of 30 Sep 2022,
CTI BIOPHARMA CORP - COM (CTIC) was held by
126 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,341,618 shares.
The largest 10 holders included
STATE STREET CORP, BVF INC/IL, BlackRock Inc., Stonepine Capital Management, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Bleichroeder LP, NEA Management Company, LLC, Sofinnova Investments, Inc., and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
126
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.